Urology service provides faster cancer diagnosis for patients
Royal Surrey NHS Foundation Trust’s Urology service has been recognised as among the quickest in England for providing a cancer diagnosis for patients referred into the Trust. Since February, the […]
Innovative new prostate cancer treatment rolled out by Velindre Cancer Service
Velindre Cancer Service is rolling out a new, shorter radiotherapy treatment for prostate cancer, improving patient experience and making better use of treatment time. Extreme Hypofractionated Radiotherapy (EHFRT) is an […]
New clinical trial design could improve dose selection, maximising treatment efficacy and safety
Researchers have developed a new approach to help determine the optimal dose of cancer drugs, aiming to make early-stage clinical trials more transparent and better aligned with patient needs. Led […]
NHS Forth Valley Contributes to Landmark OPTIMA Breast Cancer Study
NHS Forth Valley has played a significant role in a major international study that could transform the treatment of breast cancer and reduce the need for chemotherapy for thousands of […]
The ICR and The Royal Marsden partner with Mint Medical on roll out of global AI cancer imaging tool
The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust have announced a new licensing agreement with MedTech company Mint Medical, a Snke Company, to improve monitoring […]
Laboratoires Pierre Fabre receives European Commission Approval for BRAFTOVI® (encorafenib) in combination with cetuximab and FOLFOX (fluorouracil, leucovorin, and oxaliplatin) for the first-line treatment of adult patients with BRAFV600E-mutant metastatic colorectal cancer (mCRC)
Laboratoires Pierre Fabre has announced that the European Commission (EC) has approved BRAFTOVI® (encorafenib) in combination with cetuximab and FOLFOX for the first-line treatment of adult patients with BRAFV600E-mutant metastatic […]
Addenbrooke’s innovation expands access to advanced genome testing for cancer patients nationally
A service pioneered at Addenbrooke’s Hospital that could help up to three times more cancer patients benefit from whole genome sequencing (WGS) has won a national award and been accredited […]
Clatterbridge research team given £475,000 grant to expand landmark research
A research team working with The Clatterbridge Cancer Centre has been awarded more than £475,000 from Blood Cancer UK to continue and expand UNCOVER, one of the largest blood cancer […]
Personalising treatment for an aggressive asbestos-linked cancer
A new clinical trial, led by researchers in Leicester, is investigating a new personalised treatment for patients with a rare and aggressive form of cancer, potentially giving them more time […]
Faster biological ageing may help explain why more younger adults are developing cancer
A new study published yesterday in Nature Medicine has found that people whose bodies show signs of faster biological ageing may be more likely to develop cancer earlier in life. […]
